InvestorsHub Logo
Followers 30
Posts 3404
Boards Moderated 0
Alias Born 07/25/2016

Re: OneDay4488 post# 1283

Thursday, 10/07/2021 6:18:13 AM

Thursday, October 07, 2021 6:18:13 AM

Post# of 1313
Yes, I saw that and they’re not messing around, as they’re using MCRA to help them get it approved. MCRA has huge FDA connections and it’s a big part of what they do, and succeed at. Check out just this one senior executive’s background (they all have backgrounds like this) and let’s speculate if MCRA won’t get them the approval -

February 2006, Mr. Stiegman served as the Chief of the Orthopedic Devices Branch for US Food and Drug Administration.



It almost sounds like it shouldn’t be allowed, huh? But then that’s like saying someone from the U.S. Atty’s Office shouldn’t be allowed to become a criminal defense atty - they can’t stop that either.

MCRA is also noteworthy for assisting biotech and medical small caps with selling off to the larger biotechs and med/pharmas.

I saw the results were 57% improvement in quality of life - sleep, fatigue, pain - for patients in the study. That’s impressive. Looks positive. Hopefully, the upcoming Q looks good. I’m sensing they’re going to sell off, at some point, although that might take a while.

It’s pretty nice taking control and checking out…

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NURO News